Genetic Analysis (GEAN) | Spotlight

Home

Genetic Analysis operates in medical technology. The company conducts research and development in the field of diagnostics, with the main focus on the human microbiome. The technology is based on the company's research platform and the products are used, for example, for testing and analysis of bacteria and other viruses. The largest operations are in the Nordic market.

Quotes for Genetic Analysis AS

Right Now

+/-: -0.09
%: -3,01%
Latest: 2.9
High: 2.9
Low: 2.62
Volume: 3 629
Turnover (NOK): 9 975
Market Value (MNOK): 72,3
Time (Latest trade)

Board

CEO

Ronny Hermansen

Chairperson of the Board

Per Matsson

Board

Ashok Shah
Camilla Huse Bondesson
Rune Sørum
Staffan Strömberg

News

2022-06-22 10:00:00 Genetic Analysis and Servatus enter Strategic Collaboration Agreement to develop new microbiome diagnostic and therapeutic solutions
2022-06-22 10:00:00 Genetic Analysis och Servatus ingår ett strategiskt samarbetsavtal för att gemensamt utveckla nya mikrobiom-diagnostiska och terapeutiska lösningar
2022-06-16 14:00:00 Norne Securities initiates coverage of Genetic Analysis
2022-05-20 08:00:00 Genetic Analysis AS: Mandatory notification of trade – Primary Insider
2022-05-19 08:00:00 Genetic Analysis AS and Omnigene Medical Technologies Ltd. enter a distribution agreement to launch GA-map[®] in the United Arabic Emirates (UAE) market

Show More

News agencies

2022-06-22 10:13:46 Finwire: Genetic Analysis ingår samarbetsavtal med australienskt bolag
2022-05-20 11:01:04 Finwire: Genetic Analysis vd Ronny Hermansen ökar sitt aktieinnehav
2022-05-19 08:18:24 Finwire: Genetic Analysis tecknar distributionsavtal för Förenade Arabemiraten
2022-05-13 14:55:42 Direkt: INTERVJU OM Q1 2022 MED VD RONNY HERMANSEN
2022-05-13 08:40:07 Direkt: NETTORESULTATET BLEV -7,7 MLN NOK 1 KV

Show More

Analysis

2022-05-10 Mangold: Genetic Analysis: Bättre maghälsa med nytt test - Mangold

Key Numbers

*Compiled data from Millistream

Upcoming reports

2022-08-18 Delårsrapport 2022-Q2
2022-11-01 Delårsrapport 2022-Q3

Annual reports, prospectus etc.